BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8428922)

  • 1. A trisaccharide acceptor analog for N-acetylglucosaminyltransferase V which binds to the enzyme but sterically precludes the transfer reaction.
    Khan SH; Crawley SC; Kanie O; Hindsgaul O
    J Biol Chem; 1993 Feb; 268(4):2468-73. PubMed ID: 8428922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptor-substrate recognition by N-acetylglucosaminyltransferase-V: critical role of the 4"-hydroxyl group in beta-D-GlcpNAc-(1-->2)-alpha-D-Manp(1-->6)-beta-D-Glcp-OR.
    Kanie O; Crawley SC; Palcic MM; Hindsgaul O
    Carbohydr Res; 1993 Apr; 243(1):139-64. PubMed ID: 8324760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of the acceptor beta-D-GlcpNAc-(1-->2)-alpha-D-Manp- (1-->6)-beta-D-Glcp-OR by N-acetyl-glucosaminyltransferase-V: none of the hydroxyl groups on the Glc-residue are important.
    Linker T; Crawley SC; Hindsgaul O
    Carbohydr Res; 1993 Jul; 245(2):323-31. PubMed ID: 8370029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of beta-D-GlcpNAc-(1-->2)-5a-carba-alpha-D-Man p-(1-->6)-beta-D- Glcp-O(CH2)7CH3: a reactive acceptor analog for N-acetylglucosaminyltransferase-V.
    Ogawa S; Furuya T; Tsunoda H; Hindsgaul O; Stangier K; Palcic MM
    Carbohydr Res; 1995 Jul; 271(2):197-205. PubMed ID: 7664300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of N-acetylglucosaminyltransferase V activity. Kinetic comparisons of parental, Rous sarcoma virus-transformed BHK, and L-phytohemagglutinin-resistant BHK cells using synthetic substrates and an inhibitory substrate analog.
    Palcic MM; Ripka J; Kaur KJ; Shoreibah M; Hindsgaul O; Pierce M
    J Biol Chem; 1990 Apr; 265(12):6759-69. PubMed ID: 2157709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key involvement of all three GlcNAc hydroxyl groups in the recognition of beta-D-GlcpNAc-(1-->2)-alpha-D-Manp-(1-->6)-beta-D-Glcp-OR by N-acetylglucosaminyltransferase-V.
    Kanie O; Crawley SC; Palcic MM; Hindsgaul O
    Bioorg Med Chem; 1994 Nov; 2(11):1231-41. PubMed ID: 7757419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I.
    Zhang W; Betel D; Schachter H
    Biochem J; 2002 Jan; 361(Pt 1):153-62. PubMed ID: 11742540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New synthetic trisaccharide inhibitors for N-acetylglucosaminyltransferase-V.
    Lu PP; Hindsgaul O; Compston CA; Palcic MM
    Bioorg Med Chem; 1996 Nov; 4(11):2011-22. PubMed ID: 9007284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substrate specificity of the snail Lymnaea stagnalis UDP-GlcNAc:GlcNAc beta-R beta 4-N-acetylglucosaminyltransferase reveals a novel variant pathway of complex-type oligosaccharide synthesis.
    Bakker H; Schoenmakers PS; Koeleman CA; Joziasse DH; van Die I; van den Eijnden DH
    Glycobiology; 1997 Jun; 7(4):539-48. PubMed ID: 9184835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzyme.
    Reck F; Meinjohanns E; Springer M; Wilkens R; Van Dorst JA; Paulsen H; Möller G; Brockhausen I; Schachter H
    Glycoconj J; 1994 Jun; 11(3):210-6. PubMed ID: 7841796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of tetrasaccharide analogues of the N-glycan substrate of beta-(1-->2)-N-acetylglucosaminyltransferase II using trisaccharide precursors and recombinant beta-(1-->2)-N-acetylglucosaminyltransferase I.
    Reck F; Springer M; Paulsen H; Brockhausen I; Sarkar M; Schachter H
    Carbohydr Res; 1994 Jun; 259(1):93-101. PubMed ID: 8039192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analogues.
    Brockhausen I; Reck F; Kuhns W; Khan S; Matta KL; Meinjohanns E; Paulsen H; Shah RN; Baker MA; Schachter H
    Glycoconj J; 1995 Jun; 12(3):371-9. PubMed ID: 7496152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic synthesis of blood group A and B trisaccharide analogues.
    Seto NO; Compston CA; Szpacenko A; Palcic MM
    Carbohydr Res; 2000 Feb; 324(3):161-9. PubMed ID: 10724530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-3R beta 1-2-N-acetylglucosaminyltransferase I. Substrate specificity and inhibitors for the enzyme.
    Reck F; Springer M; Meinjohanns E; Paulsen H; Brockhausen I; Schachter H
    Glycoconj J; 1995 Dec; 12(6):747-54. PubMed ID: 8748150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of glycoprotein synthesis: substrate specificity of rat liver UDP-GlcNAc:Man alpha 3R beta 2-N-acetylglucosaminyltransferase I using synthetic substrate analogues.
    Möller G; Reck F; Paulsen H; Kaur KJ; Sarkar M; Schachter H; Brockhausen I
    Glycoconj J; 1992 Aug; 9(4):180-90. PubMed ID: 1422138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular dichroic spectroscopy of N-acetylglucosaminyltransferase V and its substrate interactions.
    Zhang N; Peng KC; Chen L; Puett D; Pierce M
    J Biol Chem; 1997 Feb; 272(7):4225-9. PubMed ID: 9020137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases.
    Hindsgaul O; Kaur KJ; Srivastava G; Blaszczyk-Thurin M; Crawley SC; Heerze LD; Palcic MM
    J Biol Chem; 1991 Sep; 266(27):17858-62. PubMed ID: 1917926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-N-trifluoroacetylglucosamine as an alternative substrate in N-acetylglucosaminyltransferase reactions.
    Sala RF; MacKinnon SL; Palcic MM; Tanner ME
    Carbohydr Res; 1998 Jan; 306(1-2):127-36. PubMed ID: 9691444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of glycoproteins by N-acetylglucosaminyltransferase V is greatly influenced by accessibility of the enzyme to oligosaccharide acceptors.
    Do KY; Fregien N; Pierce M; Cummings RD
    J Biol Chem; 1994 Sep; 269(38):23456-64. PubMed ID: 7522229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of eight aminodeoxy trisaccharide inhibitors for N-acetylglucosaminyltransferase-V.
    Lu PP; Hindsgaul O; Li H; Palcic MM
    Carbohydr Res; 1997 Sep; 303(3):283-91. PubMed ID: 9373934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.